With strong five-year survival rates, you can be confident that the treatment you receive at Sentara Martha Jefferson Hospital is the best available.

The National Cancer Database (NCDB) publishes survival data based on individual hospitals submission of data. Each year, we compare the Sentara Martha Jefferson Cancer Center five-year survival rates with those of the NCDB, as well as with other Commission on Cancer recognized Comprehensive Community Cancer Programs. Sentara Martha Jefferson Hospital's survival rates are comparatively strong in most of the major cancer sites.

This success highlights the vital role of the Sentara Martha Jefferson primary care physicians in facilitating appropriate screenings for earlier diagnosis of their patients and our many specialty physicians who work collaboratively to provide multidisciplinary care. To improve the outcomes for non-small-cell lung cancer, the hospital now offers a high-risk lung cancer screening. The goal is to increase the likelihood of diagnosing lung cancers earlier in the course of the disease, while it is still curable.

In addition, though we do not enter the information into the NCDB, we track the outcomes for our head and neck cancer patients. For these patients, the overall survival rates (reflecting death due to all causes, not just from cancer of the head and neck) of our head and neck cancer patients compare favorably with the national statistics both by stage and overall.

We are committed to continuously improve our care, enhancing both the patient experience and their ultimate outcomes.

For a complete list of outcomes and quality data, view our latest annual report.